Regulation of nitric oxide synthase activity by tetrahydrobiopterin in human placentae from normal and pre-eclamptic pregnancies

Z. Kukor, S. Valent, M. Tóth

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The possible regulatory role of tetrahydrobiopterin (BH4) in Type III nitric oxide synthase (NOS III) activity of human placentae from first trimester, term and pre-eclamptic pregnancies was investigated. In homogenates of first-trimester or term placentae, BH4 stimulated NOS III activity up to 2.5-fold in a concentration dependent manner from 20 nM to 1 μM BH4, and half-maximal stimulation (EC50) was observed at 100-110 nM. No significant further stimulation was detectable over an extended concentration range from 1 μM to 50 μM BH4. NOS III present in microsomal and gel-filtered cytosol fractions exhibited similar BH4-activation patterns, with an identical EC50 value of 50 nM. Remarkably, tissue concentrations of BH4 showed a marked decrease in term placentae (57 ± 23 nM, mean ± s.d., n=26) relative to first-trimester placentae (189 ± 79 nM, mean ± s.d., n=17), suggesting that alterations in cellular BH4 concentrations may play a more significant role in the regulation of NOS III activity in late pregnancy. Placental homogenates from 10 pre-eclamptic pregnancies exhibited two distinct types of response to BH4. In seven placental homogenates, addition of physiological concentrations of BH4 (20 nM to 1 μM) elicited no increase whatsoever in basal NOS III activity, and only high BH4 concentrations (50 μM) caused notable stimulation (BH4 resistant group). In contrast, in three of 10 placental homogenates both physiological and 50 μM BH4 concentrations stimulated NOS III to levels similar to that of normal placentae (BH4, responsive group). There were no appreciable differences in the clinical presentation of pre-eclampsia between the two groups. Importantly, BH4 concentrations in pre-eclamptic placentae were comparable with those of normal, control placentae. Taken together, the observations suggest that BH4 controls NOS III activity in the human placenta, and a defect in BH4 regulation of NOS III may contribute to the development of pre-eclampsia. A model implicating the malfunction of placental NOS III rather than its actual tissue level in the pathogenesis of pre-eclampsia is discussed. (C) 2000 Harcourt Publishers Ltd.

Original languageEnglish
Pages (from-to)763-772
Number of pages10
JournalPlacenta
Volume21
Issue number8
DOIs
Publication statusPublished - 2000

Fingerprint

Nitric Oxide Synthase
Placenta
Pregnancy
First Pregnancy Trimester
Pre-Eclampsia
Human Activities
sapropterin
Nitric Oxide Synthase Type III
Cytosol
Gels

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Regulation of nitric oxide synthase activity by tetrahydrobiopterin in human placentae from normal and pre-eclamptic pregnancies. / Kukor, Z.; Valent, S.; Tóth, M.

In: Placenta, Vol. 21, No. 8, 2000, p. 763-772.

Research output: Contribution to journalArticle

@article{8739779fa8a04b22a7177ae2d23915d4,
title = "Regulation of nitric oxide synthase activity by tetrahydrobiopterin in human placentae from normal and pre-eclamptic pregnancies",
abstract = "The possible regulatory role of tetrahydrobiopterin (BH4) in Type III nitric oxide synthase (NOS III) activity of human placentae from first trimester, term and pre-eclamptic pregnancies was investigated. In homogenates of first-trimester or term placentae, BH4 stimulated NOS III activity up to 2.5-fold in a concentration dependent manner from 20 nM to 1 μM BH4, and half-maximal stimulation (EC50) was observed at 100-110 nM. No significant further stimulation was detectable over an extended concentration range from 1 μM to 50 μM BH4. NOS III present in microsomal and gel-filtered cytosol fractions exhibited similar BH4-activation patterns, with an identical EC50 value of 50 nM. Remarkably, tissue concentrations of BH4 showed a marked decrease in term placentae (57 ± 23 nM, mean ± s.d., n=26) relative to first-trimester placentae (189 ± 79 nM, mean ± s.d., n=17), suggesting that alterations in cellular BH4 concentrations may play a more significant role in the regulation of NOS III activity in late pregnancy. Placental homogenates from 10 pre-eclamptic pregnancies exhibited two distinct types of response to BH4. In seven placental homogenates, addition of physiological concentrations of BH4 (20 nM to 1 μM) elicited no increase whatsoever in basal NOS III activity, and only high BH4 concentrations (50 μM) caused notable stimulation (BH4 resistant group). In contrast, in three of 10 placental homogenates both physiological and 50 μM BH4 concentrations stimulated NOS III to levels similar to that of normal placentae (BH4, responsive group). There were no appreciable differences in the clinical presentation of pre-eclampsia between the two groups. Importantly, BH4 concentrations in pre-eclamptic placentae were comparable with those of normal, control placentae. Taken together, the observations suggest that BH4 controls NOS III activity in the human placenta, and a defect in BH4 regulation of NOS III may contribute to the development of pre-eclampsia. A model implicating the malfunction of placental NOS III rather than its actual tissue level in the pathogenesis of pre-eclampsia is discussed. (C) 2000 Harcourt Publishers Ltd.",
author = "Z. Kukor and S. Valent and M. T{\'o}th",
year = "2000",
doi = "10.1053/plac.2000.0584",
language = "English",
volume = "21",
pages = "763--772",
journal = "Placenta",
issn = "0143-4004",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Regulation of nitric oxide synthase activity by tetrahydrobiopterin in human placentae from normal and pre-eclamptic pregnancies

AU - Kukor, Z.

AU - Valent, S.

AU - Tóth, M.

PY - 2000

Y1 - 2000

N2 - The possible regulatory role of tetrahydrobiopterin (BH4) in Type III nitric oxide synthase (NOS III) activity of human placentae from first trimester, term and pre-eclamptic pregnancies was investigated. In homogenates of first-trimester or term placentae, BH4 stimulated NOS III activity up to 2.5-fold in a concentration dependent manner from 20 nM to 1 μM BH4, and half-maximal stimulation (EC50) was observed at 100-110 nM. No significant further stimulation was detectable over an extended concentration range from 1 μM to 50 μM BH4. NOS III present in microsomal and gel-filtered cytosol fractions exhibited similar BH4-activation patterns, with an identical EC50 value of 50 nM. Remarkably, tissue concentrations of BH4 showed a marked decrease in term placentae (57 ± 23 nM, mean ± s.d., n=26) relative to first-trimester placentae (189 ± 79 nM, mean ± s.d., n=17), suggesting that alterations in cellular BH4 concentrations may play a more significant role in the regulation of NOS III activity in late pregnancy. Placental homogenates from 10 pre-eclamptic pregnancies exhibited two distinct types of response to BH4. In seven placental homogenates, addition of physiological concentrations of BH4 (20 nM to 1 μM) elicited no increase whatsoever in basal NOS III activity, and only high BH4 concentrations (50 μM) caused notable stimulation (BH4 resistant group). In contrast, in three of 10 placental homogenates both physiological and 50 μM BH4 concentrations stimulated NOS III to levels similar to that of normal placentae (BH4, responsive group). There were no appreciable differences in the clinical presentation of pre-eclampsia between the two groups. Importantly, BH4 concentrations in pre-eclamptic placentae were comparable with those of normal, control placentae. Taken together, the observations suggest that BH4 controls NOS III activity in the human placenta, and a defect in BH4 regulation of NOS III may contribute to the development of pre-eclampsia. A model implicating the malfunction of placental NOS III rather than its actual tissue level in the pathogenesis of pre-eclampsia is discussed. (C) 2000 Harcourt Publishers Ltd.

AB - The possible regulatory role of tetrahydrobiopterin (BH4) in Type III nitric oxide synthase (NOS III) activity of human placentae from first trimester, term and pre-eclamptic pregnancies was investigated. In homogenates of first-trimester or term placentae, BH4 stimulated NOS III activity up to 2.5-fold in a concentration dependent manner from 20 nM to 1 μM BH4, and half-maximal stimulation (EC50) was observed at 100-110 nM. No significant further stimulation was detectable over an extended concentration range from 1 μM to 50 μM BH4. NOS III present in microsomal and gel-filtered cytosol fractions exhibited similar BH4-activation patterns, with an identical EC50 value of 50 nM. Remarkably, tissue concentrations of BH4 showed a marked decrease in term placentae (57 ± 23 nM, mean ± s.d., n=26) relative to first-trimester placentae (189 ± 79 nM, mean ± s.d., n=17), suggesting that alterations in cellular BH4 concentrations may play a more significant role in the regulation of NOS III activity in late pregnancy. Placental homogenates from 10 pre-eclamptic pregnancies exhibited two distinct types of response to BH4. In seven placental homogenates, addition of physiological concentrations of BH4 (20 nM to 1 μM) elicited no increase whatsoever in basal NOS III activity, and only high BH4 concentrations (50 μM) caused notable stimulation (BH4 resistant group). In contrast, in three of 10 placental homogenates both physiological and 50 μM BH4 concentrations stimulated NOS III to levels similar to that of normal placentae (BH4, responsive group). There were no appreciable differences in the clinical presentation of pre-eclampsia between the two groups. Importantly, BH4 concentrations in pre-eclamptic placentae were comparable with those of normal, control placentae. Taken together, the observations suggest that BH4 controls NOS III activity in the human placenta, and a defect in BH4 regulation of NOS III may contribute to the development of pre-eclampsia. A model implicating the malfunction of placental NOS III rather than its actual tissue level in the pathogenesis of pre-eclampsia is discussed. (C) 2000 Harcourt Publishers Ltd.

UR - http://www.scopus.com/inward/record.url?scp=0033674825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033674825&partnerID=8YFLogxK

U2 - 10.1053/plac.2000.0584

DO - 10.1053/plac.2000.0584

M3 - Article

C2 - 11095925

AN - SCOPUS:0033674825

VL - 21

SP - 763

EP - 772

JO - Placenta

JF - Placenta

SN - 0143-4004

IS - 8

ER -